Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL816653 | 0.84 | TSHR (0.40) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL7751888 | 0.82 | TSHR (0.42) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL24414202 | 0.81 | TSHR (0.37) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL3432093 | 0.79 | GAA (0.43) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL1935839 | 0.78 | TSHR (0.34) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL12616651 | 0.78 | TSHR (0.34) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL15297220 | 0.76 | CES2 (0.47) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL1335833 | 0.75 | TSHR (0.56) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL18856925 | 0.72 | TSHR (0.39) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL14963628 | 0.72 | TSHR (0.39) | TSHRHSD17B10MGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8956799-B2 | Photoacid generator and photoresist comprising same | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2015-02-17 | — | — | US | disclosed |
| US-20130171567-A1 | PHOTOACID GENERATOR AND PHOTORESIST COMPRISING SAME | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2013-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130171567-A1 | PHOTOACID GENERATOR AND PHOTORESIST COMPRISING SAME | F10, C1S, H1-0 | TSHR 622/4885HSD17B10 2485/4885MGAM 4539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.